Melotti B - Search Results

1

Folinic acid plus 5-FU based chemotherapy in squamous cell carcinoma of the head and neck: Bologna experience.

Pannuti F, Guaraldi M, Martoni A, Melotti B, Morritti MG. Pannuti F, et al. Among authors: melotti b. Ann Oncol. 1993;4 Suppl 2:45-8. doi: 10.1093/annonc/4.suppl_2.s45. Ann Oncol. 1993. PMID: 7688983

2

Chemotherapy with cisplatin, epirubicin, methotrexate in the treatment of locally advanced or metastatic transitional cell cancer of the bladder (TCC).

Lelli G, Melotti B, Pannuti F, Rossi AP, Maver P, Mannini D, Corrado G, Severini G, Bercovich E, Beghelli R, et al. Lelli G, et al. Among authors: melotti b. J Chemother. 1992 Aug;4(4):239-43. doi: 10.1080/1120009x.1992.11739172. J Chemother. 1992. PMID: 1403081 Clinical Trial.

3

Activity of high-dose epirubicin in advanced non-small cell lung cancer.

Martoni A, Melotti B, Guaraldi M, Pannuti F. Martoni A, et al. Among authors: melotti b. Eur J Cancer. 1991;27(10):1231-4. doi: 10.1016/0277-5379(91)90087-t. Eur J Cancer. 1991. PMID: 1659841 Clinical Trial.

4

High-dose epirubicin for untreated patients with advanced tumours: a phase I study.

Martoni A, Melotti B, Guaraldi M, Pacciarini MA, Riva A, Pannuti F. Martoni A, et al. Among authors: melotti b. Eur J Cancer. 1990;26(11-12):1137-40. doi: 10.1016/0277-5379(90)90270-4. Eur J Cancer. 1990. PMID: 1963544

5

Pharmacokinetics of PTT-119 in man.

Pannuti F, Coppi G, Borella F, Martoni A, Urbano L, Melotti B. Pannuti F, et al. Among authors: melotti b. Chemioterapia. 1988 Apr;7(2):113-6. Chemioterapia. 1988. PMID: 3396115

6

Epirubicin metabolism and pharmacokinetics after conventional- and high-dose intravenous administration: a cross-over study.

Camaggi CM, Strocchi E, Carisi P, Martoni A, Melotti B, Pannuti F. Camaggi CM, et al. Among authors: melotti b. Cancer Chemother Pharmacol. 1993;32(4):301-9. doi: 10.1007/BF00686176. Cancer Chemother Pharmacol. 1993. PMID: 8324872 Clinical Trial.

7

A phase II study of carboplatin and cyclophosphamide in advanced ovarian carcinoma.

Martoni A, Panetta A, Angelelli B, Melotti B, Pannuti F. Martoni A, et al. Among authors: melotti b. J Chemother. 1993 Feb;5(1):47-51. doi: 10.1080/1120009x.1993.11739209. J Chemother. 1993. PMID: 8459265 Clinical Trial.

8

A new regimen of cisplatin, epirubicin and methotrexate (PEM-3) as primary chemotherapy for locally advanced bladder cancer.

Cacciari N, Martoni A, Rossi AP, Turci P, Lelli G, Martinelli A, Maver P, Corrado F, Mannini D, Reggiani A, Concetti S, Martelli A, Melotti B, Cricca A, Zamagni C, Pannuti F. Cacciari N, et al. Among authors: melotti b. Tumori. 1996 Jul-Aug;82(4):364-8. doi: 10.1177/030089169608200413. Tumori. 1996. PMID: 8890971 Clinical Trial.

9

Combination chemotherapy with mitoxantrone, methotrexate, and mitomycin (MMM regimen) in malignant pleural mesothelioma: a phase II study.

Pinto C, Marino A, Guaraldi M, Melotti B, Piana E, Martoni A, Pannuti F. Pinto C, et al. Among authors: melotti b. Am J Clin Oncol. 2001 Apr;24(2):143-7. doi: 10.1097/00000421-200104000-00009. Am J Clin Oncol. 2001. PMID: 11319288 Clinical Trial.

10

Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.

Martoni A, Marino A, Sperandi F, Giaquinta S, Di Fabio F, Melotti B, Guaraldi M, Palomba G, Preti P, Petralia A, Artioli F, Picece V, Farris A, Mantovani L. Martoni A, et al. Among authors: melotti b. Eur J Cancer. 2005 Jan;41(1):81-92. doi: 10.1016/j.ejca.2004.08.029. Eur J Cancer. 2005. PMID: 15617993 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters